Table 1.
No. | Sex | Age | Myeloma type | Disease duration (months) | M gradient (g/l) | FLC (mg/l) | cytogenetics | Previous auto-SCT |
---|---|---|---|---|---|---|---|---|
1 | m | 69 | IgG λ | 26 | 27.75 | 287.0 (λ) | other | yes |
2 | m | 61 | IgG κ | 16 | 6.41 | 47.8 (κ) | other | yes |
3 | m | 50 | light chain λ | 37 | 0 | 1880.0 (λ) | other | yes |
4 | m | 56 | IgA κ | 27 | 28.24 | 7.0 (κ) | other | yes |
5 | f | 60 | IgG κ | 120 | 14.07 | 390.0 (κ) | n/a | yes |
6 | m | 78 | light chain κ | 91 | 0 | 469.6 (κ) | n/a | no |
7 | m | 72 | IgG κ | 11 | 0 | 18556.0 (κ) | n/a | no |
8 | f | 64 | IgG κ | 128 | 52.65 | 1426.9 (κ) | other | yes |
9 | f | 69 | IgG κ | 37 | 44.46 | 263.5 (κ) | high-risk | no |
10 | m | 74 | IgG κ | 61 | 22.41 | 611.5 (κ) | n/a | yes |
11 | m | 82 | IgA κ | 55 | 0 | 23.0 (κ) | other | no |
12 | f | 64 | IgG λ | 85 | 0.97 | 0.4 (λ) | high-risk | yes |
13 | m | 51 | light chain λ | 57 | 0 | 2644.0 (λ) | other | yes |
14 | m | 66 | light chain λ | 33 | 0 | 5260.0 (λ) | other | no |
15 | m | 65 | IgG κ | 160 | 0 | 4061.0 (κ) | other | yes |
16 | f | 66 | light chain κ | 67 | 0 | 1349.0 (κ) | n/a | yes |
17 | m | 53 | IgG κ | 47 | 6.16 | 74.5 (κ) | n/a | yes |
18 | f | 58 | light chain λ | 57 | 0 | 102.7 (λ) | n/a | yes |
19 | m | 65 | light chain κ | 106 | 0 | 14.7 (κ) | n/a | yes |
20 | m | 66 | IgG κ | 22 | 1.,57 | 270.5 (κ) | n/a | yes |
21 | f | 65 | IgA κ | 12 | 0 | 2387.0 (κ) | high-risk | yes |
22 | f | 53 | light chain κ | 121 | 0 | 99.7 (κ) | other | yes |
23 | f | 62 | light chain κ | 54 | 0 | 5243.0 (κ) | n/a | yes |
24 | f | 57 | IgG κ | 61 | 26.97 | 752.4 (κ) | high-risk | yes |
25 | m | 65 | IgA κ | 100 | 32.65 | 401.6 (κ) | high-risk | yes |
26 | f | 58 | IgA κ | 59 | 36.87 | 1306.0 (κ) | n/a | yes |
27 | m | 62 | IgG λ | 195 | 49.24 | 139.6 (λ) | other | yes |
28 | m | 67 | light chain λ | 146 | 0 | 1165.9 (λ) | n/a | yes |
29 | m | 67 | IgG κ | 38 | 33.02 | 5008.0 (κ) | high-risk | yes |
30 | m | 44 | asecetory | 16 | 0 | n/a | n/a | yes |
31 | f | 58 | light chain κ | 12 | 0 | 37.6 (κ) | high-risk | 0 |
32 | m | 73 | IgA λ | 113 | 13.19 | 4696.0 | n/a | 0 |
33 | m | 65 | IgA λ | 9 | 0 | 123.8 | high-risk | yes |
34 | m | 52 | IgG κ | 75 | 0 | 77.4 (κ) | high-risk | yes |
35 | m | 48 | IgG κ | 17 | n/a | n/a | high-risk | yes |